>AT1G71800.1 | cleavage stimulation factor putative
MASSSSQRRCVFVGNIPYDATEEQLREICGEVGPVVSFRLVTDRETGKPKGYGFCEYKDE
ETALSARRNLQSYEINGRQLRVDFAENDKGTDKTRDQSQGGPGLPSTTTVTESQKQIGGP
VDSNMHQPVGLHLATTAASVIAGALGGPQVGSQFTQSNLQVPASDPLALHLAKMSRSQLT
EIISSIKLMATQNKEHARQLLVSRPQLLKAVFLAQVMLGIVSPQVLQSPNIVQAPSHMTG
SSIQDAQLSGQNLLPPLAQRSQQLSRAPHSQYPVQQSSKQPFSQIPQLVAQPGPSSVNPP
PRSQVKVENAPFQRQQVVPASTNIGYSSQNSVPNNAIQPSQVPHQALPNSVMQQGGQTVS
LNFGKRINEGPPHQSMNRPSKMMKVEDRRTTSLPGGHVSNSMLPNQAQAPQTHISPDVQS
TLLQQVMNLTPEQLRLLTPEQQQEVLKLQQALKQDHMMQPS*
>AT5G25150.1 | TAF5 (TBP-ASSOCIATED FACTOR 5) nucleotide binding / transcription regulator
MDPEQINEFVVGYLKKKGFSSAAKDLESYHHQNNNGSSFTSVDYHNDPELTKLIRSFSQQ
EDDPTRYREGYSKLRSWAYNSLDLYKHELLRVMYPVFIHCYMDLVGKGHTQEARAFFNSF
RKDHEMVHLRDLQKLEGVLSPSHLEEMEFARSLRKSKVNIKFCQYSYELLLQYLHSTVST
LMLGIINEHINFQVYSGQPTSSSDDIEAVTIVGSFQDTANHINQKEIQWGLLEDSLEDRL
EKTGGLLSDSEKGQGESKDGDADDSKKRSTEIGKQGSSLKKLKKDKAGNATAKVARLETI
TVSPAPRVKPELALPVMSTDVEQSILEDLRNRVQLSSVAMPSVSFYTFVNTHNGLNCSSI
SHDGSLVAGGFSDSSIKVWDMAKIGQAGSGALQAENDSSDQSIGPNGRRSYTLLLGHSGP
VYSATFSPPGDFVLSSSADTTIRLWSTKLNANLVCYKGHNYPVWDAQFSPFGHYFASCSH
DRTARIWSMDRIQPLRIMAGHLSDVDCVQWHPNCNYIATGSSDKTVRLWDVQTGECVRIF
IGHRSMVLSLAMSPDGRYMASGDEDGTIMMWDLSTARCITPLMGHNSCVWSLSYSGEGSL
LASGSADCTVKLWDVTSSTKLTKAEEKNGNSNRLRSLRTFPTKSTPVHALRFSRRNLLFA
AGAISKPAN*
>AT1G17760.1 | CSTF77 protein binding
MADKYIVEEAEALAKRALHSPIAQATPIYEQLLSLYPTSARFWKQYVEAQMAVNNDDATK
QIFSRCLLTCLQVPLWQCYIRFIRKVYDKKGAEGQEETTKAFEFMLNYIGTDIASGPIWT
EYIAFLKSLPALNLNEDLHRKTALRKVYHRAILTPTHHVEQLWKDYENFENTVNRQLAKG
LVNEYQPKFNSARAVYRERKKYIEEIDWNMLAVPPTGTSKEETQWVAWKKFLSFEKGNPQ
RIDTASSTKRIIYAYEQCLMCLYHYPDVWYDYAEWHVKSGSTDAAIKVFQRALKAIPDSE
MLKYAFAEMEESRGAIQSAKKLYENILGASTNSLAHIQYLRFLRRAEGVEAARKYFLDAR
KSPSCTYHVYIAFATMAFCIDKEPKVAHNIFEEGLKLYMSEPVYILKYADFLTRLNDDRN
IRALFERALSTLPVEDSAEVWKRFIQFEQTYGDLASILKVEQRMKEALSGKGEEGSSPPE
SSLQDVVSRYSYMDLWPCTSNDLDHLARQELLVKNLNKKAGKTNLPHVPAAIGSVASSSK
VVYPDTSQMVVQDPTKKSEFASSANPVAASASNTFPSTVTATATHGSASTFDEIPKTTPP
ALVAFLANLPIVDGPTPNVDVVLSICLQSDFPTGQTVKQSFAAKGNPPSQNDPSGPTRGV
SQRLPRDRRATKRKDSDRQEEDDTATVQSQPLPTDVFRLRQMRKARGIATSSQTPTGSTS
YGSAFSGELSGSTG*
>AT2G20510.1 | ATTIM44-1 protein-transmembrane transporting ATPase
MAIRKIIRDLLITKQPLLRQLFHQRRANARSEFLPAIGYTSHRRFSVFTEFSKNIRGEAH
SNPEFERTVKELKERTEEFKGVTEDLKVRTKQTTEKLYKQADGVWTEAESAAKKVSSSVK
DKLSAASEEVKESFKLGKEENAESASSSGTRASQGEKQQSGSTEELHTFFAKFKSSLSSP
KVSEVFYRLKEAKPFDIVKQALDIVKDELRGNPSRKKFLEHTPPPPFTGERSMRTEMVVT
QTKQSKLQQKWESFREKMQGSPVFKRLSGMSEPVVNKSQEIAEDVREIWETSDNPIVHKI
QDMNEKFLKETDSASTYKEIRSRDPSFSLPDFAAEIEEVIKPVLNAYSEGDVETLKKYCS
KEVIERCTAERTAYQTHGVLFDNKLLHISEVSVSVTKMMGDSPIIIAKFQTQEIYCVRDE
NGEIQEGGQDTIHTVYHEWAMQQVETTELGEDAIYPIWRLREMCRNGVQALI*
>AT2G17200.1 | ubiquitin family protein
MGGEGDSSQPQSGEGEAVAVNIRCSNGTKFSVKTSLDSTVESFKELVAQSSDVPANQQRL
IYKGRILKDDQTLLSYGLQADHTIHMVRGSAPSSAPPPAPAASQTTAPSVTRGVGSDNSS
NLGGASPGESLFPGLGFNPLGGGNAMSGLFGAGLPDLVQTQQQLAQNPNMIRDMMNTPAI
QNLMNNPEFMRSMIMNNPQMRELVDRNPELGHVLNDPSILRQTLEAARNPELMREMMRNT
DRAMSNIESMPEGFNMLRRMYENVQEPLMNATTMSGNAGNNTGSNPFAALLGNQGVTTQG
SDASNNSSTPNAGTGTIPNANPLPNPWGATGGQTTAPGRTNVGGDARSPGLGGLGGLGSL
GGLGGLGMLGADSPLGATPDASQLSQLLQNPAISQMMQSVFSNPQYMNQLMSLNPQLRSM
LDSNPQLREMMQNPDFLRQFSSPEMMQQMMTLQQSLSQNRNTASQDAGQTGAATGNNGGL
DLLMNMFGSLGAGGLSGTNQSNVPPEERYATQLQQLQEMGFYDRAENIRALLATNGNVNA
AVERLLGSIGQ*
>AT5G01400.1 | ESP4 (ENHANCED SILENCING PHENOTYPE 4) binding
MASYSRARLKDLANSAKSATELPPKLQRLRYMRRDLQKDDSVFPTELLPHLFDLLSDQFG
AVRKFVAEILGEIGLKYVELIPEIVPLLIKSLEDETPAVARQVIACGADLFRSTLERVAV
QGLHSSELNDLLESSWTWLIKFKDEICSVAFKQGNSGVKLCAMKFVEALILLYTPHEGIE
ADFNISILRGGHPVLKIGDLSIEASQKLGLLLDQLRHPAAKSLNSSTIIVLINSLSSVAK
KRPAYCGRILPVLLSLDPLSFLKGVYAAATNLALKTVFLSCLKCTHPAAAPDRLTSALKE
IEGGGQAAKAKDLFYKTNGSIQDKDSVEDTKVSVEENPLCASSDVAESNLSRKRSGSEYN
IDLNGDASDGKRARITPSVSEESTDGLNGNDGVSLPRVASTSTGPSDSRGVSDSGPAQQL
VGLFGTLVSQGEKAIGSLEILISSISADLLTDVVMANMHNIPPNCSSYADGTDELVMNMC
IVGSDAQIKYPPSFVAGVLSLSTAFPPIAALINPHNEDEEVYSVHVDQQMFPAEDARTPP
GLLATCDTSFPENEESNTVSPQNVHYIGNRESGIPGLESSAQHDGSGALVTNVLSSTNVE
AASKNQNASFSGKLLVDVIPSMSVDKLEEFSPKAVGTVASASQFVLPKISAPVVDLSDEE
KDSLQKLVFLRIVEAYKQISMSGGSQLRFSLLAHLGVEFPSELDPWKILQEHVLSDYLNH
EGHELTVRVLYRLYGEAEAEQDFFSSTTAASAYESFLLTVAEALRDSFPPSDKSLSKLLG
DSPHLPKSVLMLLESFCCPGSGEVEKDLQHGDRVTQGLSAVWSLILMRPGIRNDCLNIAL
QSAVHHLEEIRMKAIRLVANKLYSLSFITEQIEEFAKDRLFSVVSDDCDKMDLDLKSPPN
KPQHSISGMSMETPSEATSSSTSVTEAQRCLSLYFALCTKVLRIFTILRLMTNLVFNIYK
NASDPVKQAIHLQIPILVRTMGSSSELLKIIADPPSGSDNLLIQVLQTLTEGPTPSSELI
LTIRKLFDTRIKDVEILFPILPFLPRDDVLRIFPHMVNLPMEKFQVALSRVLQGSSQSGP
VLSPSEALIAIHSIDPARDGIPLKQVTDACNTCFAQRQTFTQQVLAGVLNQLVQQIPLPM
LFMRTVLQAIGAFPALSDFILEILSRLVSKQIWKYPKLWVGFLKCTQTTQPQSYKVLLQL
PPLQLGNALTKIPALRAPLTAHASQPEIQSSLPRSTLAVLGLVPDSQGTQTSQVQANETQ
TSQEQQQQQASEPQQTSQSQQVSVPLSHSQVDHQEPSQVVASQSQSSPIGTVQSAMSQSQ
NSPIDTGRSEMSQSQNSPIDTGRSEMSQSQNSPIDTGRSEMSQSQNSPIDTGRSEMSESQ
SSPIGQSQSSPIGTGQSDMSQTPQVSDSSAPEPTSHTRTSDPQASSQTLRDDDEKIDDTA
TSENEVTEIEKSKESSEEEEEEEEEEE*
>AT1G80460.1 | NHO1 (nonhost resistance to P s phaseolicola 1) carbohydrate kinase/ glycerol kinase
MAKENGFIGSIDQGTTSTRFIIYDHDARPVASHQVEFTQFYPEAGWVEHDPMEILESVKV
CIAKALDKATADGHNVDGGLKAIGLTDQRETTVVWSKSTGLPLHKAIVWMDARTSSICRR
LEKELSGGRSHFVESCGLPISTYFSAMKLLWLMENVDDVKDAIKKGDAIFGTIDTWLIWN
MTGGINGGLHVTDVTNASRTMLMNLKTLSWDQDTLKTLGIPAEILPKIVSNSEVIGEICK
GWPIPGIKIAGCLGDQHAAMLGQACRKGEAKSTYGTGAFILLNTGEVPIKSGHGLLTTLA
YKLGPQAQTNYALEGSIAIAGAAVQWLRDSLGIIKSASEIEDLAAMVDSTGGVYFVPAFN
GLFAPWWREDARGVCIGITRFTNKSHIARAVLESMCFQVKDVLDSMNKDAGEKGSLNNGK
GEFLLRVDGGATANNLLMQIQADLMGSPVVRPVDIETTALGAAYAAGLAVGFWKEADIFE
SGEKAKNSKVFRPAMEEGIRKKKVASWCKAVERTFDLADLSI*
>AT1G80460.1 | NHO1 (nonhost resistance to P s phaseolicola 1) carbohydrate kinase/ glycerol kinase
MAKENGFIGSIDQGTTSTRFIIYDHDARPVASHQVEFTQFYPEAGWVEHDPMEILESVKV
CIAKALDKATADGHNVDGGLKAIGLTDQRETTVVWSKSTGLPLHKAIVWMDARTSSICRR
LEKELSGGRSHFVESCGLPISTYFSAMKLLWLMENVDDVKDAIKKGDAIFGTIDTWLIWN
MTGGINGGLHVTDVTNASRTMLMNLKTLSWDQDTLKTLGIPAEILPKIVSNSEVIGEICK
GWPIPGIKIAGCLGDQHAAMLGQACRKGEAKSTYGTGAFILLNTGEVPIKSGHGLLTTLA
YKLGPQAQTNYALEGSIAIAGAAVQWLRDSLGIIKSASEIEDLAAMVDSTGGVYFVPAFN
GLFAPWWREDARGVCIGITRFTNKSHIARAVLESMCFQVKDVLDSMNKDAGEKGSLNNGK
GEFLLRVDGGATANNLLMQIQADLMGSPVVRPVDIETTALGAAYAAGLAVGFWKEADIFE
SGEKAKNSKVFRPAMEEGIRKKKVASWCKAVERTFDLADLSI*
>AT1G80460.2 | NHO1 (nonhost resistance to P s phaseolicola 1) carbohydrate kinase/ glycerol kinase
MAKENGFIGSIDQGTTSTRFIIYDHDARPVASHQVEFTQFYPEAGWVEHDPMEILESVKV
CIAKALDKATADGHNVDGGLKAIGLTDQRETTVVWSKSTGLPLHKAIVWMDARTSSICRR
LEKELSGGRSHFVESCGLPISTYFSAMKLLWLMENVDDVKDAIKKGDAIFGTIDTWLIWN
MTGGINGGLHVTDVTNASRTMLMNLKTLSWDQDTLKTLGIPAEILPKIVSNSEVIGEICK
GWPIPGIKIAGCLGDQHAAMLGQACRKGEAKSTYGTGAFILLNTGEVPIKSGHGLLTTLA
YKLGPQAQTNYALEGSIAIAGAAVQWLRDSLGIIKSASEIEDLAAMVDSTGGVYFVPAFN
GLFAPWWREDARGVCIGITRFTNKSHIARAVLESMCFQVKDVLDSMNKDAGEKGSLNNGK
GEFLLRVDAVGFWKEADIFESGEKAKNSKVFRPAMEEGIRKKKVASWCKAVERTFDLADL
SI*
>AT1G80460.2 | NHO1 (nonhost resistance to P s phaseolicola 1) carbohydrate kinase/ glycerol kinase
MAKENGFIGSIDQGTTSTRFIIYDHDARPVASHQVEFTQFYPEAGWVEHDPMEILESVKV
CIAKALDKATADGHNVDGGLKAIGLTDQRETTVVWSKSTGLPLHKAIVWMDARTSSICRR
LEKELSGGRSHFVESCGLPISTYFSAMKLLWLMENVDDVKDAIKKGDAIFGTIDTWLIWN
MTGGINGGLHVTDVTNASRTMLMNLKTLSWDQDTLKTLGIPAEILPKIVSNSEVIGEICK
GWPIPGIKIAGCLGDQHAAMLGQACRKGEAKSTYGTGAFILLNTGEVPIKSGHGLLTTLA
YKLGPQAQTNYALEGSIAIAGAAVQWLRDSLGIIKSASEIEDLAAMVDSTGGVYFVPAFN
GLFAPWWREDARGVCIGITRFTNKSHIARAVLESMCFQVKDVLDSMNKDAGEKGSLNNGK
GEFLLRVDAVGFWKEADIFESGEKAKNSKVFRPAMEEGIRKKKVASWCKAVERTFDLADL
SI*
>AT2G17190.1 | ubiquitin family protein
MGGEADSRQPLTAEGVAVAVNVRCSNGTKFSVTTSLDSTVESFKELIAQNSDVPANQQRL
IYKGRILKDDQTLLSYGLQADHTVHMVRGFVPSSPSAPAANAGNQTTAPQAVGSNDSSNL
GGGESLFPGLGFNPLGGGNAMAGLFGSGLPDLEQAQQQLAQNPNMIREMMNTPAIQNLMN
NPEFMRSMIMNNPQMRELVDRNPELGHVLNDPSILRQTLEAARNPELMREMMRNTDRAMS
NIESMPEGFNMLRRMYENVQEPLMNATTMSENAGNNTSSNPFAALLGNQGVTTQGSDTSN
NISAPNAETGTPNANPLPNPWGATAGQTTAPGRTNAGLGGLGGLGGLGGLGMLGADSPLG
ATPDASQLSQILQNPAMSQMMQSVLSNPQYMNQLMSLNPQLRSMLDMNPQLREMMQNPDF
LRQFSSPEMMQQMMSLQQSLFSQNRNTAGQDPTQTGAATGTANNGGLDLLMNMFGSLGAG
GLSGTNQPNVPPEERFATQLQQLQEMGFYDRAENIRALLATNGNVNAAVERLLGSIGQ*